Preclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer

Preclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer

Bibliographic Details
Main Authors:	Sakellariou-Thompson, Donastas, Haymaker, Cara, Forget, Marie-Andree, Jazaeri, Amir, Hwu, Patrick, Bernatchez, Chantale
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646126/

Similar Items

You can run but you can't hide: tracking T cells in metastatic melanoma patients treated with tumor-infiltrating lymphocytes
by: Haymaker, Cara, et al.
Published: (2015)

BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties
by: Haymaker, Cara L, et al.
Published: (2015)

The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacity
by: Forget, Marie-Andrée, et al.
Published: (2015)

Uncovering a novel function of BTLA on tumor-infiltrating CD8+ T cells
by: Haymaker, Cara, et al.
Published: (2013)

Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy
by: Chen, Jie Qing, et al.
Published: (2013)

Genetically modified artificial antigen-presenting cells (aAPC) for expansion of melanoma tumor infiltrating lymphocytes with optimal properties for adoptive cell therapy
by: Forget, Marie-Andrée, et al.
Published: (2013)

Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy
by: Chen, Jieqing, et al.
Published: (2014)

Modification of BTLA signaling motifs in TIL exhibits positive signals that mediate anti-tumor control
by: Ritthipichai, Krit, et al.
Published: (2015)

Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity
by: Malu, Shruti, et al.
Published: (2013)

Prognostic and biologic significance of high LCK expression in ovarian cancer
by: Jazaeri, Amir, et al.
Published: (2015)

PD-1 and BTLA and CD8+ T-cell “exhaustion” in cancer: “Exercising” an alternative viewpoint
by: Haymaker, Cara, et al.
Published: (2012)

Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma
by: Reuben, Alexandre, et al.
Published: (2014)

Single-cell motility and gene expression signature as predictors of the overall survival of act in melanoma patients
by: Martinez-Paniagua, Melisa, et al.
Published: (2015)

Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case report
by: Uemura, Marc, et al.
Published: (2016)

Tumor-infiltrating T lymphocyte clonality predicts prognosis in human ovarian cancer
by: Tsuji, Takemasa, et al.
Published: (2013)

Identification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer
by: Deniger, Drew C, et al.
Published: (2015)

Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung Cancer
by: Im, Jin S., et al.
Published: (2016)

A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1
by: Uemura, Marc, et al.
Published: (2016)

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes
by: Milne, Katy, et al.
Published: (2012)

Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
by: Bellone, Matteo, et al.
Published: (2013)

The antigen specific composition of melanoma tumor infiltrating lymphocytes?
by: Hadrup, Sine Reker
Published: (2012)

Relevance of tumor-infiltrating lymphocytes in breast cancer
by: Dushyanthen, Sathana, et al.
Published: (2015)

Clinical significance of tumor-infiltrating lymphocytes in breast cancer
by: Stanton, Sasha E., et al.
Published: (2016)

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
by: Fortes, Cristina, et al.
Published: (2015)

Characterization and quantification of tumor infiltrating lymphocytes in breast cancer
by: Bedri, Shahinaz, et al.
Published: (2014)

Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy
by: Kodumudi, Krithika N., et al.
Published: (2016)

Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
by: Sarnaik, Amod, et al.
Published: (2015)

Tumor-infiltrating lymphocytes in breast cancer: A new predictor for responses to therapy
by: Issa-Nummer, Yasmin, et al.
Published: (2014)

Generation of tumor-infiltrating lymphocytes from pancreatic cancer lesions for cellular therapy
by: Meng, Qingda, et al.
Published: (2014)

Immediate triggering of 4-1BB co-stimulation during initiation of tumor-infiltrating lymphocyte (TIL) expansion from melanoma tumors accelerates CD8+ T-cell outgrowth and tumor specificity
by: Chacon, Jessica, et al.
Published: (2013)

Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8+ tumor-infiltrating lymphocytes in ovarian cancer
by: Webb, John R, et al.
Published: (2014)

Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
by: Hall, MacLean, et al.
Published: (2016)

Identification of tumor-specific T cell receptors from primary tumor-infiltrating lymphocytes
by: Kishi, Hiroyuki, et al.
Published: (2015)

The Significance of Lymphocytic Infiltration in Neuroblastoma
by: Lauder, I., et al.
Published: (1972)

Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy
by: Chacon, Jessica Ann, et al.
Published: (2013)

Modulation of immune cell infiltrate with sunitinib to improve anti-PD1 therapy in preclinical tumor model
by: Rayman, Patricia, et al.
Published: (2015)

Marrow-Infiltrating Lymphocytes – Role in Biology and Cancer Therapy
by: Borrello, Ivan, et al.
Published: (2016)

Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast
by: Toss, Michael S., et al.
Published: (2018)

Won’t you come on in? How to favor lymphocyte infiltration in tumors
by: Bellone, Matteo, et al.
Published: (2012)

Distribution, function and predictive value of tumor-infiltrating γδ T lymphocytes
by: Dieli, Francesco, et al.
Published: (2013)